Multicenter and population cohort studies suggest that patients with inflammatory bowel disease (IBD) are not at unique risk of contracting…
Browsing: Hot headlines in GI
Today, the U.S. Food and Drug Administration released the agency’s first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD)…
For several years, scientists worldwide have been investigating the extent to which microorganisms living in and on the human body…
Young adult survivors of colorectal cancer exhibited low overall health-related quality of life scores, with longer-term survivors reporting worse social…
A recently approved injectable gel that aids in lifting and differentiating the mucosa from the muscularis propria in endoscopic and…
We performed a prospective, endoscopist-blinded study of 500 patients undergoing split-dose bowel preparation for CRC screening or surveillance colonoscopies at…
The global pandemic has proved a catalyst for reshaping health care as venture capitalists reached deep into their pockets to…
It was one year ago — Jan. 20, 2020 — that the first case of SARS-CoV-2 infection was reported on U.S. soil.…
Here are four updates from GI companies and practices over the past week: Investing firm Assured Healthcare Partners partnered with West Long…
Adding bemarituzumab to chemotherapy as first-line treatment for advanced gastric and gastroesophageal junction (GEJ) cancers improved survival over chemotherapy alone…